comparemela.com

Carlf Nathan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Grants will fund tuberculosis drug development

Weill Cornell Medicine researchers and the TB Drug Accelerator have received two grants totaling $6.8 million from the Bill & Melinda Gates Foundation to study tuberculosis (TB) drug development. This effort will expedite finding new drug targets

Dirk schnappingerSabine ehrtMichael glickmanCarlf nathanSloan kettering institutePathogen biology at rockefeller universityWorld health organizationMelinda gates foundationLaboratory of hostWeill cornell medicineWorld healthJeremy rockHost pathogen biologyCornell medicine

Grants will fund tuberculosis drug development

Weill Cornell Medicine researchers and the TB Drug Accelerator have received two grants totaling $6.8 million from the Bill & Melinda Gates Foundation to study tuberculosis drug development.

Dirk schnappingerCarlf nathanMichael glickmanSabine ehrtPathogen biology at rockefeller universityWorld health organizationLaboratory of hostSloan kettering instituteMelinda gates foundationWeill cornell medicineWorld healthJeremy rockHost pathogen biologyCornell medicine

Researchers receive two grants to study tuberculosis drug development

Weill Cornell Medicine researchers and the TB Drug Accelerator have received two grants totaling $6.8 million from the Bill & Melinda Gates Foundation to study tuberculosis (TB) drug development.

Michael glickmanSabine ehrtCarlf nathanDirk schnappingerLaboratory of hostWorld health organizationPathogen biology at rockefeller universityMelinda gates foundationSloan kettering instituteCornell medicineWeill cornell medicineWorld healthJeremy rockHost pathogen biologyChest painInfectious diseases

vimarsana © 2020. All Rights Reserved.